Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer. Zhu X, Fu Z, Dutchak K, Arabzadeh A, et al. Cancer Res 2024;84:1333-1351.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu X, Fu Z, Dutchak K, Arabzadeh A, et al. Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer. Cancer Res 2024;84:1333-1351.
PMID: 38277141